AAAAAA

   
Results: 1-13 |
Results: 13
MECHANICAL VENTILATION - PREFACE
Authors: THARRATT RS
Citation: Rs. Tharratt, MECHANICAL VENTILATION - PREFACE, Critical care clinics, 14(4), 1998, pp. 11-12
ISOLATED TRANSIENT LOSS OF CONSCIOUSNESS IS AN INDICATOR OF SIGNIFICANT INJURY
Authors: OWINGS JT WISNER DH BATTISTELLA FD PERLSTEIN J WALBY WF THARRATT RS
Citation: Jt. Owings et al., ISOLATED TRANSIENT LOSS OF CONSCIOUSNESS IS AN INDICATOR OF SIGNIFICANT INJURY, Archives of surgery, 133(9), 1998, pp. 941-945
SEDATING PATIENTS IN INTENSIVE-CARE UNITS
Authors: THARRATT RS ALBERTSON TE
Citation: Rs. Tharratt et Te. Albertson, SEDATING PATIENTS IN INTENSIVE-CARE UNITS, Western journal of medicine, 166(1), 1997, pp. 56-57
SOCIETY AND TOXICOLOGY - A DOUBLE-STANDARD - OR OF MICE AND TOADS ...(WITH APOLOGIES TO MR STEINBECK)
Authors: ALBERTSON TE THARRATT RS
Citation: Te. Albertson et Rs. Tharratt, SOCIETY AND TOXICOLOGY - A DOUBLE-STANDARD - OR OF MICE AND TOADS ...(WITH APOLOGIES TO MR STEINBECK), Chest, 110(5), 1996, pp. 1139-1141
DEVELOPING GUIDELINES FOR BIOTECHNOLOGY DRUG-USE - EXPERIENCE WITH ANTITHROMBIN-III
Authors: ROMAC DR POOLE P OWINGS JT MAHACKIAN K FOULKE G THARRATT RS ALBERTSON TE
Citation: Dr. Romac et al., DEVELOPING GUIDELINES FOR BIOTECHNOLOGY DRUG-USE - EXPERIENCE WITH ANTITHROMBIN-III, Formulary, 30(9), 1995, pp. 520
FENTANYL REMAINING IN A TRANSDERMAL SYSTEM FOLLOWING 3 DAYS OF CONTINUOUS USE
Authors: MARQUARDT KA THARRATT RS MUSALLAM NA
Citation: Ka. Marquardt et al., FENTANYL REMAINING IN A TRANSDERMAL SYSTEM FOLLOWING 3 DAYS OF CONTINUOUS USE, The Annals of pharmacotherapy, 29(10), 1995, pp. 969-971
THE PHARMACOLOGY AND TOXICOLOGY OF 3 NEW BIOLOGIC AGENTS USED IN PULMONARY MEDICINE
Authors: ALBERTSON TE WALBY WF ALLEN RP THARRATT RS
Citation: Te. Albertson et al., THE PHARMACOLOGY AND TOXICOLOGY OF 3 NEW BIOLOGIC AGENTS USED IN PULMONARY MEDICINE, Journal of toxicology. Clinical toxicology, 33(5), 1995, pp. 427-438
INHALATION ABUSE OF FENTANYL PATCH
Authors: MARQUARDT KA THARRATT RS
Citation: Ka. Marquardt et Rs. Tharratt, INHALATION ABUSE OF FENTANYL PATCH, Journal of toxicology. Clinical toxicology, 32(1), 1994, pp. 75-78
SAFETY AND POTENTIAL EFFICACY OF AN AEROSOLIZED SURFACTANT IN HUMAN SEPSIS-INDUCED ADULT-RESPIRATORY-DISTRESS-SYNDROME
Authors: WEG JG BALK RA THARRATT RS JENKINSON SG SHAH JB ZACCARDELLI D HORTON J PATTISHALL EN
Citation: Jg. Weg et al., SAFETY AND POTENTIAL EFFICACY OF AN AEROSOLIZED SURFACTANT IN HUMAN SEPSIS-INDUCED ADULT-RESPIRATORY-DISTRESS-SYNDROME, JAMA, the journal of the American Medical Association, 272(18), 1994, pp. 1433-1438
SAFETY AND POTENTIAL EFFICACY OF AN AEROSOLIZED SURFACTANT IN HUMAN SEPSIS-INDUCED ADULT-RESPIRATORY-DISTRESS-SYNDROME
Authors: WEG JG BALK RA THARRATT RS JENKINSON SG SHAH JB ZACCARDELLI D HORTON J PATTISHALL EN
Citation: Jg. Weg et al., SAFETY AND POTENTIAL EFFICACY OF AN AEROSOLIZED SURFACTANT IN HUMAN SEPSIS-INDUCED ADULT-RESPIRATORY-DISTRESS-SYNDROME, JAMA, the journal of the American Medical Association, 272(18), 1994, pp. 1433-1438
GREENFIELD INFERIOR VENA-CAVA FILTER DISLODGED DURING CENTRAL VENOUS CATHETER PLACEMENT
Authors: MARELICH GP THARRATT RS
Citation: Gp. Marelich et Rs. Tharratt, GREENFIELD INFERIOR VENA-CAVA FILTER DISLODGED DURING CENTRAL VENOUS CATHETER PLACEMENT, Chest, 106(3), 1994, pp. 957-959
SURVIVAL OF PATIENTS UNDERGOING ND-YAG LASER THERAPY COMPARED WITH ND-YAG LASER THERAPY AND BRACHYTHERAPY FOR MALIGNANT AIRWAY DISEASE
Authors: SHEA JM ALLEN RP THARRATT RS SIEFKIN AD
Citation: Jm. Shea et al., SURVIVAL OF PATIENTS UNDERGOING ND-YAG LASER THERAPY COMPARED WITH ND-YAG LASER THERAPY AND BRACHYTHERAPY FOR MALIGNANT AIRWAY DISEASE, Chest, 106(2), 1994, pp. 650-650
INITIATION OF A CLINICAL-PHARMACOLOGY CONSULT SERVICE AS A FORMULARY MANAGEMENT TOOL
Authors: ALBERTSON T MUSALLAM N THARRATT RS ROMAC D FOULKE G MOWERS R PANECEK E
Citation: T. Albertson et al., INITIATION OF A CLINICAL-PHARMACOLOGY CONSULT SERVICE AS A FORMULARY MANAGEMENT TOOL, Hospital formulary, 28(8), 1993, pp. 699-707
Risultati: 1-13 |